Matthew A. Velykis v. Melinda Adams, Facility Manager, et. al.

CourtDistrict Court, W.D. Pennsylvania
DecidedJune 10, 2026
Docket2:25-cv-01344
StatusUnknown

This text of Matthew A. Velykis v. Melinda Adams, Facility Manager, et. al. (Matthew A. Velykis v. Melinda Adams, Facility Manager, et. al.) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Matthew A. Velykis v. Melinda Adams, Facility Manager, et. al., (W.D. Pa. 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA MATTHEW A. VELYKIS, ) Plaintiff, v. ) Civil No. 25-1344 MELINDA ADAMS, Facility Manager, et. al, ) ) Defendants. )

MEMORANDUM OPINION and ORDER This case has been referred to United States Magistrate Judge Kezia O. L. Taylor for pretrial proceedings in accordance with the Magistrate Judges Act, 28 U.S.C. § 636(b)(1), and Rule 72 of the Local Rules for Magistrate Judges. On April 27, 2026, the Magistrate Judge issued a Report and Recommendation, ECF No. 66, recommending that Plaintiff, Matthew A. Velykis’s Amended Emergency Motion for Temporary Restraining Order and Preliminary Injunction, ECF No. 46, be denied. Mr. Velykis timely filed Objections by mail on May 11, 2026, which were then filed on the docket on May 14, 2026. ECF No. 69. The filing of timely objections requires the district judge to “make a de novo determination of those portions of the report . . . to which objection is made.” 28 U.S.C. § 636(b)(1); Sample v. Diecks, 885 F.2d 1099, 1106 n. 3 (3d Cir. 1989); Fed. R. Civ. P. 72(b)(3). As explained below, the Court finds that Plaintiff's Objections do not undermine the recommendation of the Magistrate Judge. I. Discussion The relevant procedural and factual background of this case are presented in the Magistrate Judge’s Report. ECF No. 66, at 1-2, 3. Mr. Velykis suffers from Opioid Use Disorder,

which is often treated with Medication Assisted Treatment, such as oral Suboxone. Mr. Velykis has been successfully treated with Suboxone in the past, but he alleges that he was denied Suboxone from July 2021 through November 2025. Suboxone was eventually prescribed and provided to him in November 2025. Sometime in January 2026, the Suboxone was stopped, and Mr. Velykis’s Opioid Use Disorder was treated with a different Medication Assisted Treatment, called Sublocade injections. Mr. Velykis alleges that both the failure to provide him Suboxone until November 2025, and the January 2026 discontinuation of Suboxone treatment, violate the Eighth Amendment and the Americans with Disabilities Act. In addition, he alleges that both the initial failure to provide Suboxone, and the later change in his medication treatment, were done in retaliation for Mr. Velykis engaging in litigation activity. Finally, he alleges that prison staff have also engaged in retaliatory conduct as a result of his litigation activities. Presently at issue is Mr. Velykis’s request for a Temporary Restraining Order to require Defendants to resume administration of Suboxone and to enjoin Defendants from conducting retaliatory canine searches of his cell. Mr. Velykis ultimately seeks an injunction requiring Defendants to continue providing him with Suboxone during the pendency of this litigation. I. Objections A. The Magistrate Judge Made Factual and Legal errors Plaintiff argues that the Magistrate Judge made a plain error of fact in concluding that the prison’s provision of an alternate Medically Assisted Treatment drug, Sublocade injections, is constitutionally equivalent to treatment with Suboxone for Opioid Use Disorder. Plaintiff explains that he is asserting that the denial of his preferred, effective, medically appropriate treatment, and the replacement with an ineffective, alternative medication, constitutes deliberate indifference.

The Magistrate Judge did not make a factual or legal finding regarding the constitutional equivalency of Suboxone and Sublocade injections. The circumstances presented were that Plaintiff was provided Suboxone until he failed to comply with the Suboxone treatment protocols, after which he was prescribed Sublocade injection. Based upon these facts, the Magistrate Judge recognized that the “deliberate indifference standard ‘affords considerable latitude to prison medical authorities in the diagnosis and treatment of the medical problems of inmate patients.’” Pearson v. Prison Health Serv., 850 F.3d 526, 538 (3d Cir. 2017) (quoting Inmates of Allegheny Cty. Jail v. Pierce, 612 F.2d 754, 762 (3d Cir. 1979)). Courts “‘disavow any attempt to second-guess the propriety or adequacy of [their] particular course of treatment’ so long as it ‘remains a question of sound professional judgment.’” Jd. This is the case here: medical staff changed Plaintiffs medication for his Opioid Use Disorder. Defendants have not refused to medically address Plaintiff's Disorder, although Plaintiff views the medication switch as ineffective. The Court views Plaintiffs position as evidencing a disagreement between the Defendants’ attempts to treat Plaintiff and Plaintiff's views of how he should be medically treated. Spruill v. Gillis, 372 F.3d 218, 235 (3d Cir. 2004) (disagreement as to proper medical treatment insufficient to state Eighth Amendment claim). Thus, the Magistrate Judge did not make a legal or factual error as to this issue. Accordingly, this objection is overruled. B. The Use of the Substitute Medication Vivitrol is Functionally No Treatment This is not really an objection by Plaintiff, but a complaint that a substitute medication for Opioid Use Disorder Plaintiff used to take, Vivitrol, is ineffective. The record reflects that for several years prior to being provided with Suboxone in November 2025, Plaintiff had received monthly Vivitrol injections. This is a different medication from the Sublocade injections given to Plaintiff in January 2026. To the extent that Vivitrol was a selected medication treatment for

Plaintiff in the years and months before he started on Suboxone in November 2025, such a course of alternative medication treatment also amounts to a disagreement over treatment, which falls below the standard for an Eighth Amendment deliberate indifference claim. This objection is overruled. . C. The Magistrate Judge Erred by Not Finding that the Denial of Suboxone Constitutes Deliberate Indifference Plaintiff argues that the Magistrate Judge erred in not concluding that denying a person Suboxone amounts to deliberate indifference. Plaintiff argues that the substitution of other medications is not medically equivalent to Suboxone. He cites two cases in support of his argument, but both are readily distinguishable. In Smith v. Aroostook County, the jail had preemptively announced it was not going to provide Smith with her medication, it was not going to conduct a medical assessment of Smith, and it noted that it had reasonable alternative medications; but it did not intend to provide her with any medication. 922 F.3d 41 (1st Cir. 2019). Smith faced a complete denial of medication treatment for her Opioid Use Disorder. The Smith case is thus not comparable to the present case. Similarly, in Pesce v. Coppinger, the correctional facility “expressly prohibits opioids like suboxone and methadone;” and, as “part of its substance abuse treatment program, [the prison] requires incarcerated individuals to undergo forced withdrawal under medical supervision.” 355 F. Supp. 3d 35, 42 (D. Mass. 2018).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sample v. Diecks
885 F.2d 1099 (Third Circuit, 1989)
Antonio Pearson v. Prison Health Service
850 F.3d 526 (Third Circuit, 2017)
Smith v. Aroostook County
922 F.3d 41 (First Circuit, 2019)
Pesce v. Coppinger
355 F. Supp. 3d 35 (District of Columbia, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Matthew A. Velykis v. Melinda Adams, Facility Manager, et. al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/matthew-a-velykis-v-melinda-adams-facility-manager-et-al-pawd-2026.